Latest Safety News

Elders Limited reported a robust FY25 with a 12% rise in underlying EBIT to $143.5 million, driven by strong livestock prices and real estate growth despite challenging seasonal conditions. The acquisition of Delta Agribusiness and ongoing systems modernization underpin the company’s diversified growth strategy.

Elders Limited reported a robust FY25 with a 12% rise in underlying EBIT to $143.5 million and declared a fully franked final dividend of 18 cents per share. The agribusiness is optimistic about FY26, buoyed by strategic acquisitions and a new divisional model.

Stealth Group Holdings has acquired Hardware & Building Traders for $22 million, significantly expanding its footprint and upgrading its FY28 sales target to over $500 million. The deal positions Stealth as a formidable independent competitor in Australia’s hardware and industrial distribution market.

Predictive Discovery Limited’s definitive feasibility study for the Bankan Gold Project in Guinea reveals a substantial 2.95 million ounce gold reserve and strong project economics, supported by comprehensive environmental and social approvals.

Wagners Holding Company Limited reported a strong FY25 with profits more than doubling, driven by robust construction demand in Southeast Queensland and growth in composite fibre technologies. The company raised $30 million to expand its concrete plants and composite production capacity, positioning for further growth in FY26.

AXP Energy reports encouraging early oil and gas flowback at its Charlie #1 well in Oklahoma, marking a key milestone in its Mississippi Lime development program.

DPM Metals delivered record third quarter financial results driven by strong free cash flow and adjusted net earnings, while its recent acquisition of Adriatic Metals' Vareš operation promises higher-than-expected production in 2026.

Veganic SKN Ltd has launched legal action against Cancer Council Australia over alleged misleading claims about chemical UV filters in sunscreens, coinciding with recent product recalls and the company’s ambitious growth plans for 2026.

PYC Therapeutics reports sustained vision improvements in patients with Retinitis Pigmentosa type 11 treated with VP-001, showing promising safety and efficacy up to 18 months. The company plans to engage the FDA in early 2026 to finalize pivotal trial design.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.

Chimeric Therapeutics reports promising interim results from its CHM CDH17 Phase 1/2 trial, with 75% disease control at 28 days and durable responses in gastrointestinal cancers.

NEXTDC’s FY25 Annual General Meeting reveals robust financial growth, significant data centre expansions, and enhanced funding capacity to capitalise on AI infrastructure demand.